ImageneBio Inc
Price Action
Technical Summary
WEAKENINGImageneBio Inc is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 36), showing significant lag compared to the market leaders. Earnings contraction of 428% provides fundamental context to the price action. Investors should exercise caution due to high volatility (74% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $5.71 | +2.59% | ABOVE |
| 50 SMA | $5.74 | +1.97% | ABOVE |
| 100 SMA | $5.89 | -0.53% | BELOW |
| 150 SMA | $6.16 | -4.95% | BELOW |
| 200 SMA | $6.67 | -12.19% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is IMA in an uptrend right now?
IMA has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is IMA overbought or oversold?
IMA's RSI (14) is 56. The stock is in neutral territory, neither overbought nor oversold.
Is IMA outperforming the market?
IMA has a Relative Strength (RS) Rating of 36 out of 99. IMA is currently lagging the broader market.
Where is IMA in its 52-week range?
IMA is trading at $5.86, which is 33% of its 52-week high ($18.00) and 27% above its 52-week low ($1.36).
How volatile is IMA?
IMA has a Beta of 0.82 and 52-week volatility of 74%. It's less volatile than the S&P 500 - generally more stable.